A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients w...
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
About this item
Full title
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
Author / Creator
Publisher
London: BioMed Central
Journal title
Infectious agents and cancer, 2012-04, Vol.7 (S1), p.O15-O15, Article O15
Language
English
Formats
Publication information
Publisher
London: BioMed Central
Subjects
More information
Scope and Contents
Contents
Doc number: O15
Alternative Titles
Full title
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bb5bcdcc0bbb487996a075846b9fd3d2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bb5bcdcc0bbb487996a075846b9fd3d2
Other Identifiers
ISSN
1750-9378
E-ISSN
1750-9378
DOI
10.1186/1750-9378-7-S1-O15
How to access this item
Log in as a Library member
